Table 2.
Effects of TGF-β1 on liver fibrosis indexes (mean ± SD, n = 3).
| Group | Dose (ng·mL−1) | LN (μg·L−1) | HA (ng·L−1) | PCIII (μg·L−1) |
|---|---|---|---|---|
| Blank control | — | 51.8 ± 0.78 | 26.9 ± 5.67 | 18.8 ± 4.53 |
| Model group (TGF-β1) | 100 | 833.4 ± 9.94## | 302.3 ± 7.44## | 115.3 ± 3.38## |
Compared with the blank control group (#P < 0.05, ##P < 0.01).